Overview
Valued at
~$24.16 billion in 2023, the gastrointestinal endoscopy devices market is projected
to reach
~$33.05 billion by 2028, increasing at a
CAGR of 6.5% over the
2023-2028 forecast period. This Market Snapshot is part of
LSI’s Market Intelligence platform, your
one-stop-shop for global medtech market sizing and analysis, procedure volume data, startup company- and
deal-tracking, curated insights, and more.
Endoscopy is a minimally invasive procedure that enables visualization, diagnosis, and surgical intervention
within the body. The procedures involve the introduction of a flexible, fiberoptic scope into the upper or lower
gastrointestinal (GI) tract. Endoscopy serves a crucial role in minimally invasive examination and treatment,
making it easier to diagnose and address medical issues with reduced postoperative complications.
Products included within the scope of this analysis include:
GI endoscopes for imaging
GI endoscopic instruments for intervention
This Market Snapshot is intended to provide a high-level overview of the global market for gastrointestinal
endoscopy devices, with key insights into:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups
Gastrointestinal Endoscopy Devices Market Snapshot Summary
Snapshot Aspect |
Data and Details |
Base Year for Estimate |
2023 |
Forecast Period |
2023 - 2028 |
Market Size in 2023 |
$24.16 billion |
CAGR |
6.5% |
Projected Market Size in 2028 |
$33.05 billion |
Gastrointestinal Endoscopy Devices Market Insights
The gastrointestinal endoscopy devices market is experiencing steady growth, driven by the ongoing shift from
open surgical procedures to less invasive laparoscopic and endoscopic techniques. Advances in device technology,
including robotic surgery systems, enhanced imaging and guidance technologies, and more effective energy-based
tools, enable these less invasive procedures. These innovations are making endoscopic surgeries increasingly
accessible, offering numerous advantages over traditional open surgery, such as reduced trauma, less
postoperative pain, shorter recovery times, and improved cosmetic outcomes.
The market is growing particularly quickly in other developing/developed regions, such as China and India. While
the overall market is expanding, prices are expected to increase at a slower rate compared to the broader
medical device market due to intense competition and price sensitivity in emerging markets.
Competitive Landscape
The full Market Snapshot includes a robust analysis of the competitive landscape for the gastrointestinal
endoscopy devices market. This includes estimated market revenue and market share for key players, such as
Ethicon/Johnson & Johnson, Medtronic, and Olympus.
Select Market Events
Company
|
Date
|
Type
|
Event
|
|
5/2024
|
Regulatory Approval
|
Medtronic received U.S. FDA 510(k) clearance for its PillCam Genius SB capsule kit, used in
small bowel endoscopy.
|
|
10/2023
|
Product Launch
|
Olympus announced the market launch of its EVIS X1 endoscopy system.
|
Key Companies Covered
Applied Medical
Aqua Medical
B. Braun
Boston Scientific
ConMed
Ethicon
Integra Lifesciences
Intuitive Surgical
Johnson & Johnson
KARL STORZ
Medtronic
Olympus
Purple Surgical
Richard Wolf
Stryker
Teleflex